Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
February 5, 2014 3 afeyan noubar HTML PDF XLS Add to Briefcase
March 24, 2014 4 afeyan, noubar HTML PDF XLS Add to Briefcase
December 6, 2016 8-K/A amended current report HTML PDF XLS Add to Briefcase
September 19, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
September 23, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 18, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 30, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 6, 2015 10-Q/A amended quarterly report HTML PDF XLS Add to Briefcase
October 13, 2010 D/A amended small company offering and sale of securities without registration HTML PDF
Add to Briefcase
January 21, 2015 SC 13G/A amended statement of beneficial ownership HTML PDF XLS Add to Briefcase
1
... NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
2.01
Change:
+ 0.11
Day High:
2.34
Day Low:
1.97
Volume:
3,691,299
4:00 PM ET on March 24, 2017
Delayed at least 20 minutes.